<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.883560</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Role of Cytokines in Thymic Regulatory T Cell Generation: Overview and Updates</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Mei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jia</surname>
<given-names>Fuya</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1695317"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nan</surname>
<given-names>Fang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zuo</surname>
<given-names>Fengqiong</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Zhu</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Dunfang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/923868"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>West China School of Pharmacy, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Immunology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Bin Zhao, Central South University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Shunqun Luo, National Cancer Institute (NIH), United States; Yan Lu, Third Affiliated Hospital of Sun Yat-sen University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Dunfang Zhang, <email xlink:href="mailto:izdf@163.com">izdf@163.com</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>883560</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Tang, Jia, Nan, Zuo, Yuan and Zhang</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Tang, Jia, Nan, Zuo, Yuan and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Regulatory (Treg) T cells are mainly generated within the thymus. However, the mechanism of thymic Treg cell (tTreg cell) generation remains to be fully revealed. Although the functions of TCR/CD28 co-stimulation have been widely accepted, the functions of cytokines in the generation of tTreg cells remain highly controversial. In this review, we summarize the existing studies on cytokine regulation of tTreg cell generation. By integrating the key findings of cytokines in tTreg cell generation, we have concluded that four members of &#x3b3;c family cytokines (IL-2, IL-4, IL-7 and IL-15), transforming growth factor &#x3b2; (TGF-&#x3b2;), and three members of TNF superfamily cytokines (GITRL, OX40L and TNF-&#x3b1;) play vitally important roles in regulating tTreg cell generation. We also point out all disputed points and highlight critical scientific questions that need to be addressed in the future.</p>
</abstract>
<kwd-group>
<kwd>tTreg cells</kwd>
<kwd>IL-2</kwd>
<kwd>IL-15</kwd>
<kwd>TGF-&#x3b2;</kwd>
<kwd>&#x3b3;c family cytokines</kwd>
<kwd>TNF superfamily</kwd>
<kwd>TNFRSF</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="99"/>
<page-count count="8"/>
<word-count count="3654"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>CD4<sup>+</sup> Regulatory T (Treg) cells that express IL-2 receptor &#x3b1;-chain (CD25) and the transcription factor forkhead box P3 (Foxp3) are the major cell population that maintains immune tolerance (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref>). Since these cells were identified in 1995 (<xref ref-type="bibr" rid="B2">2</xref>), Treg cells have been demonstrated to play extremely important roles in maintaining tolerance to auto-antigens (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>) and commensal microbiota (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>), controlling maternal-fetal immune interactions (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>), and suppressing overactive immune responses during infection (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). On the other hand, Treg cell-mediated immune suppression can also promote tumor immune escape (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Therefore, targeting Treg cells could be a promising strategy to treat autoimmune disorders, maternal-fetal conflict, infections, and malignant tumors.</p>
<p>A majority of Treg cells are generated in the thymus (thymic Treg cells, tTreg cells), however some Treg cells can also be generated in periphery (pTreg cells) (<xref ref-type="bibr" rid="B17">17</xref>). Although it has been well documented that tTreg cells are generated during CD4<sup>+</sup> thymocyte development, the clear mechanisms of tTreg cell development is still not completely understood. Since T-cell receptor (TCR) stimulation from self-antigens and CD28 co-stimulation during thymocyte development are indispensable for tTreg cell generation (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>), the mainstream view once believed that high-affinity TCR signal is the main driving force for inducing Treg cell differentiation (<xref ref-type="bibr" rid="B21">21</xref>&#x2013;<xref ref-type="bibr" rid="B23">23</xref>). However, later studies demonstrated that tTreg cells could be generated from developing CD4<sup>+</sup> thymocytes expressing TCRs with a broad range of self-reactivity (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>), showing that the self-reactivity of the TCR signal is not the deciding factor for tTreg cell generation.</p>
<p>In contrast, a two-step model of tTreg cell generation is gaining acceptance (<xref ref-type="bibr" rid="B26">26</xref>&#x2013;<xref ref-type="bibr" rid="B29">29</xref>). The first step is driven by self-antigen induced TCR stimulation and CD28 co-stimulation, which leads to differentiation of CD4<sup>+</sup> CD8<sup>-</sup> Foxp3<sup>-</sup> CD25<sup>+</sup> tTreg cell precursors (CD25<sup>+</sup> Foxp3<sup>-</sup> tTreg precursors) and CD4<sup>+</sup> CD8<sup>-</sup> Foxp3<sup>+</sup> CD25<sup>-</sup> Treg cell precursors (Foxp3<sup>+</sup> CD25<sup>-</sup> tTreg precursors) from developing CD4<sup>+</sup> CD8<sup>-</sup> thymocytes. The second step relies on IL-2, which leads to the generation of CD25<sup>+</sup>Foxp3<sup>+</sup> mature tTreg cells from CD25<sup>+</sup> Foxp3<sup>-</sup> tTreg precursors and Foxp3<sup>+</sup> CD25<sup>-</sup> tTreg precursors. This model proposes that both precursor populations are induced by TCR/CD28 co-stimulation, and both precursor populations rely on IL-2 to differentiate into mature tTreg cells. However, one recent study indicated that CD25<sup>+</sup> Foxp3<sup>-</sup> tTreg precursors and Foxp3<sup>+</sup> CD25<sup>-</sup> tTreg precursors are generated through two distinct developmental programs (<xref ref-type="bibr" rid="B30">30</xref>), suggesting that besides TCR/CD28 co-stimulation, some other key factors must be involved during development of these two tTreg precursor populations. All this evidence shows that this model still needs further refinements.</p>
<p>Besides TCR/CD28 co-stimulation, the most probable factors that mediate the distinct developmental programs of tTreg cell are different cytokines. Other than IL-2 and IL-15, three members of the tumor necrosis factor (TNF) superfamily cytokines (GITRL, OX40L and TNF-&#x3b1;) were demonstrated to promote tTreg generation (<xref ref-type="bibr" rid="B31">31</xref>). Moreover, TGF-&#x3b2; has also been shown to be important for tTreg cell generation (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B32">32</xref>). In this review, we summarize the existing studies showing the important functions of cytokines in tTreg cell generation. We conclude that IL-2, IL-7, IL-15, IL-4, TGF-&#x3b2;, GITRL, OX40L, and TNF-&#x3b1; all play important roles in regulating tTreg cell generation, although regulation mechanisms of these cytokines have yet to be confirmed.</p>
</sec>
<sec id="s2">
<title>Four &#x3b3;c Family Cytokines (IL-2, IL-7, IL-15 and IL-4)</title>
<sec id="s2_1">
<title>Function of IL-2, IL-7, IL-15 and IL-4 in tTreg Cell Generation</title>
<p>Before Treg cells were well identified, it was determined that mice deficient in IL-2 (<xref ref-type="bibr" rid="B33">33</xref>&#x2013;<xref ref-type="bibr" rid="B35">35</xref>), IL-2 receptor &#x3b1; chain (IL-2R&#x3b1;, also called CD25) (<xref ref-type="bibr" rid="B36">36</xref>) or IL-2 receptor &#x3b2; chain (IL-2R&#x3b2;, also called CD122) (<xref ref-type="bibr" rid="B37">37</xref>) would develop severe autoimmunity. It was a surprising finding since IL-2 was found to be a critical T cell growth factor (<xref ref-type="bibr" rid="B38">38</xref>&#x2013;<xref ref-type="bibr" rid="B40">40</xref>). Since Treg cells have been identified, CD25 was proven to be a surface marker of Treg cells (<xref ref-type="bibr" rid="B2">2</xref>), and then it was determined that Treg cell-deficient scurfy mice develop severe autoimmunity as well (<xref ref-type="bibr" rid="B3">3</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B41">41</xref>). These findings suggested that IL-2 might play a vital role in Treg cell generation.</p>
<p>However, the function of IL-2 in tTreg cell generation is still contentious. Some studies are against the idea that IL-2 is key for tTreg cell generation, because a significant number of CD4<sup>+</sup> CD8<sup>-</sup> CD25<sup>-</sup> FOXP3<sup>+</sup> thymocytes were still present in IL-2 knockout (<italic>Il2</italic>
<sup>-/-</sup>) mice, and these cells could still suppress inflammation in adaptive transfer mice model (<xref ref-type="bibr" rid="B42">42</xref>&#x2013;<xref ref-type="bibr" rid="B44">44</xref>), although CD25<sup>-</sup> FOXP3<sup>+</sup> thymocytes were defined as tTreg precursors in the two-step model (<xref ref-type="bibr" rid="B29">29</xref>). Moreover, a recent study found that IL-2 could modulate the tTreg cell epigenetic landscape by targeting genome wide chromatin accessibility (<xref ref-type="bibr" rid="B45">45</xref>). These studies showed that IL-2 is dispensable for tTreg cell development, but important for mature tTreg cell survival, tTreg cell stabilization, and tTreg cell suppression function. Consistent with this idea, it was determined that Foxp3 is a proapoptotic protein and these Foxp3<sup>+</sup> CD25<sup>-</sup> tTreg precursors completed for the limited IL-2 to support their survival (<xref ref-type="bibr" rid="B28">28</xref>). In contrast, some studies found that although mice deficient in IL-2 or IL-2R&#x3b1; had a certain number of Foxp3+ cells, their tTreg cells were not mature, and mice deficient in IL-2R&#x3b2; were shown to have a significant decrease in Treg numbers (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B46">46</xref>), suggesting IL-2 should be important for tTreg cell development. Consistent with this idea, in the two-step model of tTreg cell development, it was found that CD25<sup>+</sup> FOXP3<sup>-</sup> tTreg precursors needed IL-2 to convert to mature tTreg cells (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>IL-2 receptor &#x3b3; chain (IL-2R&#x3b3;), also known as the common cytokine receptor &#x3b3; chain (&#x3b3;c) or CD132, is a common component of the receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 (&#x3b3;c family cytokines) (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). Therefore, besides IL-2, functions of other &#x3b3;c family cytokines in tTreg cell generation have also attracted a lot of attention. Importantly, mice deficient in IL-2R&#x3b2; resulted in a large reduction in the number of tTreg cells, whereas mice deficient in IL-2 or IL-2R&#x3b1; still have high Foxp3 expression (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B46">46</xref>). IL-2R&#x3b2; is the receptor for both IL-2 and IL-15, so the function of IL-15 in tTreg cell generation was determined. Indeed, IL-2 and IL-15 double knockout (<italic>Il2</italic>
<sup>-/-</sup>x<italic>Il15</italic>
<sup>-/-</sup>) mice have a significant decrease in Treg numbers compared with <italic>Il2</italic>
<sup>-/-</sup> mice (<xref ref-type="bibr" rid="B44">44</xref>), showing that IL-2 and IL-15 are important for tTreg cell generation. Moreover, mice deficient in IL-2R&#x3b3; were shown to be devoid of tTreg cells and have no expression of Foxp3 (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B49">49</xref>), suggesting other &#x3b3;c family cytokines might also be important for tTreg cell generation. After in-depth research and verification, IL-7 was proven to be important for tTreg cell generation (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>). Moreover, IL-2R&#x3b2; and IL-7 receptor subunit &#x3b1; (IL-7R&#x3b1;, also known as CD127) double knockout (<italic>Il2rb</italic>
<sup>-/-</sup>x<italic>Il7ra</italic>
<sup>-/-</sup>) mice were also devoid of tTreg cells, just like mice deficient in IL-2R&#x3b3; (<xref ref-type="bibr" rid="B50">50</xref>). Further studies proved that IL-2, IL-7, and IL-15 induces STAT5 phosphorylation and this process is indispensable for tTreg cell generation (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>), as STAT5 phosphorylation is critical for tTreg cell development by regulating Foxp3 expression (<xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B55">55</xref>). Taken together, three &#x3b3;c family cytokines, IL-2, IL-7, and IL-15 are essential for Treg cell generation (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). However, it remains to be confirmed whether these cytokines mainly induce tTreg cell development, promote tTreg cell survival, and/or maintain tTreg cell stabilization.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Cytokines that are important for tTreg cell generation. Four &#x3b3;c family cytokines (IL-2, IL-4, IL-7, and IL-15), Three TNF superfamily cytokines (GITRL, OX40L, and TNF-&#x3b1;) and TGF-&#x3b2; have been determined to be important for tTreg cell generation. There may be other cytokines that are important for tTreg cell generation but have not yet been identified. It has been proven that CD4<sup>+</sup>CD8<sup>-</sup>Foxp3<sup>-</sup>CD25<sup>+</sup> thymocytes and CD4<sup>+</sup>CD8<sup>-</sup>Foxp3<sup>+</sup>CD25<sup>-</sup> thymocytes are two populations of tTreg cell precursors that generated through two distinct developmental programs, but the regulatory network of these cytokines in the development of these two precursor populations and mature tTreg cell has not been fully revealed.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-883560-g001.tif"/>
</fig>
<p>In the beginning, another &#x3b3;c family cytokine IL-4 was thought to be not important for tTreg cell generation as mice deficient in IL-4 receptor &#x3b1; (IL-4R&#x3b1;) had absolutely normal tTreg cell generation (<xref ref-type="bibr" rid="B50">50</xref>). Moreover, IL-4 was actually shown to suppress Treg cell generation and induce T helper-9 cells (Th9 cells) in periphery and <italic>in vitro</italic> (<xref ref-type="bibr" rid="B56">56</xref>&#x2013;<xref ref-type="bibr" rid="B58">58</xref>). However, The same research team corrected the views (<xref ref-type="bibr" rid="B59">59</xref>), as they found that IL-4 could promote tTreg cell generation from Foxp3<sup>+</sup> CD25<sup>-</sup> tTreg precursors, although IL-4 could not support tTreg cell generation from CD25<sup>+</sup>Foxp3<sup>-</sup> tTreg precursors (<xref ref-type="bibr" rid="B30">30</xref>). This evidence shows that IL-4 plays a role in tTreg cell development from Foxp3<sup>+</sup>CD25<sup>-</sup> tTreg precursors.</p>
</sec>
<sec id="s2_2">
<title>Source of IL-2, IL-7, IL-15 and IL-4 in the Thymus</title>
<p>Determining the cellular sources of IL-2, IL-7, and IL-15 within the thymus are important in revealing the generation of tTreg cells, and it is also important for autoimmunity treatment through the manipulation of tTreg cells. It has been shown that tTreg cells could not produce IL-2 to support tTreg cell development and survival because Foxp3 represses expression of IL-2 (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B60">60</xref>). More than that, in IL-2 wild type (<italic>Il2</italic>
<sup>+/+</sup>) and <italic>Il2</italic>
<sup>-/-</sup> bone marrow chimera mice, tTreg cell generation was totally rectified in <italic>Il2</italic>
<sup>-/-</sup> thymocytes and these bone marrow chimera mice did not develop autoimmunity (<xref ref-type="bibr" rid="B20">20</xref>). Therefore, tTreg cell generation mainly relied on IL-2 produced by non-Treg cells.</p>
<p>Although dendritic cells (DCs) and B cells were shown to be able to produce IL-2, mice that have selectively deleted IL-2 in DCs and B cells had been shown to have normal tTreg cell development and homeostasis (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>), showing DCs and B cells are not the major cellular sources of IL-2 in the thymus. In contrast, tTreg cell development was largely impaired in <italic>Il2</italic>
<sup>f/f</sup> CD4-Cre mice, suggesting T cells are the key cellular source of IL-2 in the thymus (<xref ref-type="bibr" rid="B62">62</xref>). Moreover, a recent study determined that cells that secrete IL-2 are predominantly mature CD4<sup>+</sup> CD8<sup>-</sup> (CD4SP) thymocytes in the thymus; it has further been identified that IL-2 is mainly produced by self-reactive CD4SP thymocytes through single-cell RNA sequencing analysis (<xref ref-type="bibr" rid="B63">63</xref>). This evidence shows that self-reactive CD4SP thymocytes are the major cellular sources of IL-2 in the thymus.</p>
<p>Unlike IL-2, the major cellular sources of IL-7 and IL-15 are not T cells. It was determined that both cortical thymic epithelial cells (TECs) and medullary TECs express high levels of IL-7, and IL-7 expression in cortical TECs is even higher than in medullary TECs (<xref ref-type="bibr" rid="B64">64</xref>). However, medullary TECs that highly expressed MHC class II were the major cellular source of IL-15 (<xref ref-type="bibr" rid="B65">65</xref>). Interestingly, it is well documented that tTreg cells are mainly generated in the medulla (<xref ref-type="bibr" rid="B66">66</xref>&#x2013;<xref ref-type="bibr" rid="B69">69</xref>), suggesting it might be why IL-7 is not as important as IL-2 and IL-15 during tTreg cell generation in thymus. So far, the major cellular source of IL-4 in the thymus has not been determined (<xref ref-type="bibr" rid="B30">30</xref>).</p>
</sec>
</sec>
<sec id="s3">
<title>TGF-&#x3b2;</title>
<sec id="s3_1">
<title>Function of TGF-&#x3b2; in tTreg Cell Generation</title>
<p>Although it has been determined that TGF-&#x3b2; is the key inducer of Foxp3 in periphery and <italic>in vitro</italic> (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>), the function of TGF-&#x3b2; in tTreg cell generation is still in dispute. During early research, TGF-&#x3b2; was thought to be dispensable for tTreg cell development, because TGF-&#x3b2;1 deficient (8-10 days old) mice (<italic>Tgfb1</italic>
<sup>-/-</sup>) had normal frequency of tTreg cell in thymus (<xref ref-type="bibr" rid="B72">72</xref>), and T cell-specific TGF-&#x3b2; receptor II-deficient mice (<italic>Tgfbr2</italic>
<sup>f/f</sup> x CD4-Cre) did not change the frequency of tTreg cell in thymus (12-14 days old mice) either (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>). In contrast, it was shown that TGF-&#x3b2; is critical for tTreg cell stabilization and regulatory function (<xref ref-type="bibr" rid="B72">72</xref>&#x2013;<xref ref-type="bibr" rid="B74">74</xref>). Although the same research team repudiated their earlier study and thought TGF-&#x3b2; was not important for tTreg cell function and stabilization (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>), a recent study determined that TGF-&#x3b2; is critical for tTreg cell function in specific tissue environments, but not important for tTreg cell stabilization (<xref ref-type="bibr" rid="B77">77</xref>).</p>
<p>Surprisingly, TGF-&#x3b2; was identified to be important for tTreg cell development by studying tTreg cell generation in 3-5 days old neonatal mice (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B78">78</xref>). It was shown that deletion of TGF-&#x3b2; receptor I (<italic>Tgfbr1</italic>
<sup>f/f</sup> x Lck-Cre) in T cells blocks tTreg cell development largely in 3-5 days old neonatal mice, then tTreg cell frequency was recovered and became even higher in thymus of 3-4 weeks old <italic>Tgfbr1</italic>
<sup>f/f</sup> x Lck-Cre mice than that in WT mice (<xref ref-type="bibr" rid="B32">32</xref>). It was then shown that tTreg cell frequency was increased in thymus due to increased tTreg cell proliferation in <italic>Tgfbr1</italic>
<sup>f/f</sup> x Lck-Cre mice, as thymocytes lacking TGF-&#x3b2; receptor I produced more IL-2 and tTreg cells lacking TGF-&#x3b2; receptor I proliferated much faster in response to IL-2 (<xref ref-type="bibr" rid="B32">32</xref>). More importantly, further deletion of IL-2 in <italic>Tgfbr1</italic>
<sup>f/f</sup> x Lck-Cre mice (<italic>Tgfbr1</italic>
<sup>f/f</sup> x Lck-Cre x <italic>Il2</italic>
<sup>-/-</sup>) blocked tTreg cell development and expansion totally, as 3-4 weeks old <italic>Tgfbr1</italic>
<sup>f/f</sup> x Lck-Cre x <italic>Il2</italic>
<sup>-/-</sup> mice were devoid of tTreg cells as well (<xref ref-type="bibr" rid="B32">32</xref>).</p>
<p>The other group also reported a lack of tTreg cells in the thymus of 3-5 days old neonatal <italic>Tgfbr2</italic>
<sup>f/f</sup> x CD4-Cre mice, but they proposed that this was due to increased tTreg cell apoptosis caused by the deletion of TGF-&#x3b2; signaling (<xref ref-type="bibr" rid="B78">78</xref>). Since TGF-&#x3b2; promotes thymocyte cell survival (<xref ref-type="bibr" rid="B79">79</xref>), a Treg cell-specific TGF-&#x3b2; receptor I-deficient mice (<italic>Tgfbr1</italic>
<sup>f/f</sup> x Foxp3-Cre) was generated to determine whether the main function of TGF-&#x3b2; is to promote tTreg cell survival in the thymus (<xref ref-type="bibr" rid="B25">25</xref>). Surprisingly, it was found that tTreg cell frequency and number in <italic>Tgfbr1</italic>
<sup>f/f</sup> x Foxp3-Cre mice did not decrease at all (<xref ref-type="bibr" rid="B25">25</xref>), and the aged <italic>Tgfbr1</italic>
<sup>f/f</sup> x Foxp3-Cre mice had even more tTreg cells (<xref ref-type="bibr" rid="B77">77</xref>), showing the main function of TGF-&#x3b2; in tTreg cell generation is not to support tTreg cell survival. Existing mechanism studies have found that Smad3 could bind at the conserved noncoding sequence 1 (CNS1) of Foxp3 enhancer and induce Foxp3 expression (<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>), but it was argued that Smad3 binding to the foxp3 enhancer was dispensable for tTreg cell development (<xref ref-type="bibr" rid="B82">82</xref>). Taken together, these findings show that TGF-&#x3b2; is critical to tTreg cell development, although the exact mechanisms need to be further identified (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
</sec>
<sec id="s3_2">
<title>Source of TGF-&#x3b2; in the Thymus</title>
<p>Thymocyte apoptosis has been identified to increase by day 2 after birth (<xref ref-type="bibr" rid="B83">83</xref>), TGF-&#x3b2; level was found to increase significantly in the thymus by day 3 after birth (<xref ref-type="bibr" rid="B25">25</xref>), and tTreg cells were shown to appear in large numbers in the thymus by day 3 after birth (<xref ref-type="bibr" rid="B84">84</xref>). This evidence suggests that tTreg cell generation, thymocyte apoptosis, and TGF-&#x3b2; production are highly correlated. Indeed, one study showed that the intrathymic concentration of TGF-&#x3b2; is highly dependent on thymocyte apoptosis (<xref ref-type="bibr" rid="B25">25</xref>). However, the major cellular source of TGF-&#x3b2; in the thymus has not been uncovered. Based on the existing studies, TGF-&#x3b2; is likely to be released from two possible cellular sources. The first possible source is apoptotic T cells that release TGF-&#x3b2; directly (<xref ref-type="bibr" rid="B85">85</xref>), and the second possible source is phagocytes that release TGF-&#x3b2; after these cells phagocytize apoptotic cells (<xref ref-type="bibr" rid="B86">86</xref>, <xref ref-type="bibr" rid="B87">87</xref>).</p>
<p>It is worth mentioning that TGF-&#x3b2; is secreted into the extracellular matrix in an inactive latent form (latent TGF-&#x3b2;) and needs to be activated to produce bioactive TGF-&#x3b2; (<xref ref-type="bibr" rid="B88">88</xref>, <xref ref-type="bibr" rid="B89">89</xref>). By now, it has not been determined how TGF-&#x3b2; is activated in the thymus. One possible mechanism for the activation of TGF-&#x3b2; in the thymus is through apoptotic cell-released ROS, as apoptotic thymocytes could release a high level of ROS (<xref ref-type="bibr" rid="B85">85</xref>), and ROS has been shown to induce TGF-&#x3b2; activation and promote Treg cell generation in periphery (<xref ref-type="bibr" rid="B90">90</xref>&#x2013;<xref ref-type="bibr" rid="B92">92</xref>).</p>
</sec>
</sec>
<sec id="s4">
<title>Three TNF Superfamily Cytokines (GITRL, OX40L and TNF-&#x3b1;)</title>
<sec id="s4_1">
<title>Function of GITRL, OX40L, and TNF-&#x3b1; in tTreg Cell Generation</title>
<p>The tumor necrosis factor (TNF) superfamily is a protein superfamily originally produced as type-II transmembrane proteins, but these proteins can function as cytokines once they are cleaved off the cell membrane by metalloproteinases (<xref ref-type="bibr" rid="B93">93</xref>). The receptors of the TNF superfamily are tumor necrosis factor receptor superfamily (TNFRSF) (<xref ref-type="bibr" rid="B94">94</xref>). It has been determined that CD25<sup>+</sup> Foxp3<sup>-</sup> tTreg precursors and mature tTreg cells express high levels of TNFRSF members called Glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR, also known as CD357 or TNFRSF18), OX40 (also known as CD134 or TNFRSF4) and TNFR2 (also known as CD120b or TNFRSF1B) (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B95">95</xref>). Moreover, it was found that a TNF superfamily member, TNF-&#x3b1;, a ligand of TNFR2, could promote Treg cell expansion <italic>in vivo</italic> (<xref ref-type="bibr" rid="B96">96</xref>&#x2013;<xref ref-type="bibr" rid="B98">98</xref>). These findings suggest that the TNF superfamily might be important for tTreg cell generation.</p>
<p>Three TNF superfamily members, GITRL, OX40L, and TNF-&#x3b1; have been identified to promote tTreg cell generation (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B99">99</xref>). One study reported that deficiency in TNFR2 reduced tTreg cell generation significantly (<xref ref-type="bibr" rid="B99">99</xref>). Another study showed that deficiency in all three of the TNFRSF members GITR, OX40, and TNFR2, or neutralization of TNF superfamily members GITRL, OX40L, and TNF-&#x3b1; together, markedly inhibited the generation of tTreg cells (<xref ref-type="bibr" rid="B31">31</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). It was shown that GITRL, OX40L, and TNF-&#x3b1; could convert CD25<sup>+</sup> Foxp3<sup>-</sup> tTreg precursors into mature Foxp3+ Treg cells at very low dose of IL-2 (<xref ref-type="bibr" rid="B31">31</xref>), showing these three TNF superfamily members promote tTreg cell mature from CD25<sup>+</sup> Foxp3<sup>-</sup> tTreg precursors. However, it is still not clear whether TNF superfamily members and IL-2 complement each other, or TNF superfamily members just function as compensatory signals of IL-2 signal.</p>
</sec>
<sec id="s4_2">
<title>Source of GITRL, OX40L and TNF-&#x3b1; in the Thymus</title>
<p>Although the major cellular sources of GITRL, OX40L, and TNF-&#x3b1; have not been well defined, it was identified that medullary TECs expressed GITRL, OX40L, and TNF-&#x3b1;, while conventional dendritic cells (cDCs) and plasmacytoid dendritic cells (pDCs) expressed only GITRL and TNF-&#x3b1; (<xref ref-type="bibr" rid="B31">31</xref>). Further studies are needed to determine which kind of APCs are the major cellular source of GITRL, OX40L, and TNF-&#x3b1;. Moreover, whether membrane-bound or soluble GITRL, OX40L, and TNF-&#x3b1; play a more important role in tTreg cell generation has not yet been determined either.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions and Future Perspective</title>
<p>By summarizing the existing studies of cytokines in tTreg cell generation, we conclude that four members of &#x3b3;c family cytokines (IL-2, IL-4, IL-7 and IL-15), transforming growth factor &#x3b2; (TGF-&#x3b2;), and three members of TNF superfamily cytokines (GITRL, OX40L, and TNF-&#x3b1;) play vitally important roles in regulating tTreg cell generation, although regulation mechanisms of these cytokines have yet to be confirmed. Functions of these cytokines in tTreg cell generation are still divisive. For example, opinions are still divided on the functions of TGF-&#x3b2; and IL-2, whether they are important for tTreg cell development, survival, and/or proliferation are still controversial.</p>
<p>On the other hand, when and how cytokines interact with each other and mediate tTreg cell generation in the thymus remains to be fully revealed. Also, when and how these cytokines take effect during tTreg cell development is still unclear. Therefore, future studies should focus on why developing tTreg cells are divided into two populations of tTreg precursors. Since CD25<sup>+</sup> Foxp3<sup>-</sup> tTreg precursors and Foxp3<sup>+</sup> CD25<sup>-</sup> tTreg precursors are generated through two distinct developmental programs (<xref ref-type="bibr" rid="B30">30</xref>), it is very likely that cytokines play key roles in inducing these two precursor populations besides TCR/CD28 co-stimulation. So far, it has been proven that IL-4 can support tTreg cell generation from Foxp3<sup>+</sup> CD25<sup>-</sup> tTreg precursors (<xref ref-type="bibr" rid="B30">30</xref>), and TNF superfamily cytokines (GITRL, OX40L and TNF-&#x3b1;) can support tTreg cell generation from CD25<sup>+</sup> Foxp3<sup>-</sup> tTreg precursors (<xref ref-type="bibr" rid="B31">31</xref>). These findings can partially explain the differences of CD25<sup>+</sup> Foxp3<sup>-</sup> tTreg precursors and Foxp3<sup>+</sup> CD25<sup>-</sup> tTreg precursors. However, the regulatory network of these cytokines during the development of tTreg precursors and mature tTreg cell has not yet been fully revealed. It is beyond all doubt that answering these basic questions is extremely important for fully disclosing the generation of tTreg cells.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author Contributions</title>
<p>MT drafted the manuscript. FJ, FN, FZ, and ZY reviewed and edited the manuscript. DZ supervised the work and wrote the manuscript. All authors contributed to the article and approved it for publication.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (NO. 82171829, 81600876), the Key Project of the Science and Technology Department of Sichuan Province (NO. 2022YFH0100, 2020YFS0210), the 1&#xb7;3&#xb7;5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (NO. ZYYC21012), and the Fundamental Research Funds for the Central Universities (NO. 20822041E4084).</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>DZ sincerely wants to commemorate Dr. Sang-A Park, who passed away suddenly on January 22, 2018.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaguchi</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Regulatory T Cells: Key Controllers of Immunologic Self-Tolerance</article-title>. <source>Cell</source> (<year>2000</year>) <volume>101</volume>(<issue>5</issue>):<page-range>455&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0092-8674(00)80856-9</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaguchi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sakaguchi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Asano</surname> <given-names>M</given-names>
</name>
<name>
<surname>Itoh</surname> <given-names>M</given-names>
</name>
<name>
<surname>Toda</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Immunologic Self-Tolerance Maintained by Activated T Cells Expressing IL-2 Receptor Alpha-Chains (CD25). Breakdown of a Single Mechanism of Self-Tolerance Causes Various Autoimmune Diseases</article-title>. <source>J Immunol</source> (<year>1995</year>) <volume>155</volume>(<issue>3</issue>):<page-range>1151&#x2013;64</page-range>.</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hori</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nomura</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sakaguchi</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Control of Regulatory T Cell Development by the Transcription Factor Foxp3</article-title>. <source>Science</source> (<year>2003</year>) <volume>299</volume>(<issue>5609</issue>):<page-range>1057&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1079490</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontenot</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Gavin</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Rudensky</surname> <given-names>AY</given-names>
</name>
</person-group>. <article-title>Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells</article-title>. <source>Nat Immunol</source> (<year>2003</year>) <volume>4</volume>(<issue>4</issue>):<page-range>330&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni904</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khattri</surname> <given-names>R</given-names>
</name>
<name>
<surname>Cox</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yasayko</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Ramsdell</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>An Essential Role for Scurfin in CD4+CD25+ T Regulatory Cells</article-title>. <source>Nat Immunol</source> (<year>2003</year>) <volume>4</volume>(<issue>4</issue>):<page-range>337&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni909</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malek</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Vincek</surname> <given-names>V</given-names>
</name>
<name>
<surname>Scibelli</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2Rbeta-Deficient Mice. Implications for the Nonredundant Function of IL-2</article-title>. <source>Immunity</source> (<year>2002</year>) <volume>17</volume>(<issue>2</issue>):<page-range>167&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1074-7613(02)00367-9</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kasagi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zanvit</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Manipulating Regulatory T Cells: A Promising Strategy to Treat Autoimmunity</article-title>. <source>Immunotherapy</source> (<year>2015</year>) <volume>7</volume>(<issue>11</issue>):<page-range>1201&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2217/imt.15.79</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaguchi</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Naturally Arising CD4+ Regulatory T Cells for Immunologic Self-Tolerance and Negative Control of Immune Responses</article-title>. <source>Annu Rev Immunol</source> (<year>2004</year>) <volume>22</volume>:<page-range>531&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.immunol.21.120601.141122</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cebula</surname> <given-names>A</given-names>
</name>
<name>
<surname>Seweryn</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rempala</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Pabla</surname> <given-names>SS</given-names>
</name>
<name>
<surname>McIndoe</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Denning</surname> <given-names>TL</given-names>
</name>
<etal/>
</person-group>. <article-title>Thymus-Derived Regulatory T Cells Contribute to Tolerance to Commensal Microbiota</article-title>. <source>Nature</source> (<year>2013</year>) <volume>497</volume>(<issue>7448</issue>):<page-range>258&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature12079</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Round</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Mazmanian</surname> <given-names>SK</given-names>
</name>
</person-group>. <article-title>Inducible Foxp3+ Regulatory T-Cell Development by a Commensal Bacterium of the Intestinal Microbiota</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2010</year>) <volume>107</volume>(<issue>27</issue>):<page-range>12204&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0909122107</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aluvihare</surname> <given-names>VR</given-names>
</name>
<name>
<surname>Kallikourdis</surname> <given-names>M</given-names>
</name>
<name>
<surname>Betz</surname> <given-names>AG</given-names>
</name>
</person-group>. <article-title>Regulatory T Cells Mediate Maternal Tolerance to the Fetus</article-title>. <source>Nat Immunol</source> (<year>2004</year>) <volume>5</volume>(<issue>3</issue>):<page-range>266&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni1037</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahn</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Baltimore</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Pregnancy Induces a Fetal Antigen-Specific Maternal T Regulatory Cell Response That Contributes to Tolerance</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2010</year>) <volume>107</volume>(<issue>20</issue>):<page-range>9299&#x2013;304</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1003909107</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanteri</surname> <given-names>MC</given-names>
</name>
<name>
<surname>O&#x2019;Brien</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Purtha</surname> <given-names>WE</given-names>
</name>
<name>
<surname>Cameron</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Lund</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Owen</surname> <given-names>RE</given-names>
</name>
<etal/>
</person-group>. <article-title>Tregs Control the Development of Symptomatic West Nile Virus Infection in Humans and Mice</article-title>. <source>J Clin Invest</source> (<year>2009</year>) <volume>119</volume>(<issue>11</issue>):<page-range>3266&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI39387</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oldenhove</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bouladoux</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wohlfert</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Chou</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dos Santos</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Decrease of Foxp3+ Treg Cell Number and Acquisition of Effector Cell Phenotype During Lethal Infection</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>31</volume>(<issue>5</issue>):<page-range>772&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2009.10.001</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curiel</surname> <given-names>TJ</given-names>
</name>
</person-group>. <article-title>Tregs and Rethinking Cancer Immunotherapy</article-title>. <source>J Clin Invest</source> (<year>2007</year>) <volume>117</volume>(<issue>5</issue>):<page-range>1167&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI31202</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sakaguchi</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Regulatory T Cells in Cancer Immunotherapy</article-title>. <source>Cell Res</source> (<year>2017</year>) <volume>27</volume>(<issue>1</issue>):<page-range>109&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cr.2016.151</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shevach</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Thornton</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>Ttregs, Ptregs, and Itregs: Similarities and Differences</article-title>. <source>Immunol Rev</source> (<year>2014</year>) <volume>259</volume>(<issue>1</issue>):<fpage>88</fpage>&#x2013;<lpage>102</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imr.12160</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jordan</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Boesteanu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Reed</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Petrone</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Holenbeck</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Lerman</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Thymic Selection of CD4+CD25+ Regulatory T Cells Induced by an Agonist Self-Peptide</article-title>. <source>Nat Immunol</source> (<year>2001</year>) <volume>2</volume>(<issue>4</issue>):<page-range>301&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/86302</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Apostolou</surname> <given-names>I</given-names>
</name>
<name>
<surname>Sarukhan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>L</given-names>
</name>
<name>
<surname>von Boehmer</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Origin of Regulatory T Cells With Known Specificity for Antigen</article-title>. <source>Nat Immunol</source> (<year>2002</year>) <volume>3</volume>(<issue>8</issue>):<page-range>756&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni816</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tai</surname> <given-names>X</given-names>
</name>
<name>
<surname>Cowan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Feigenbaum</surname> <given-names>L</given-names>
</name>
<name>
<surname>Singer</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>CD28 Costimulation of Developing Thymocytes Induces Foxp3 Expression and Regulatory T Cell Differentiation Independently of Interleukin 2</article-title>. <source>Nat Immunol</source> (<year>2005</year>) <volume>6</volume>(<issue>2</issue>):<page-range>152&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni1160</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stritesky</surname> <given-names>GL</given-names>
</name>
<name>
<surname>Jameson</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Hogquist</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>Selection of Self-Reactive T Cells in the Thymus</article-title>. <source>Annu Rev Immunol</source> (<year>2012</year>) <volume>30</volume>:<fpage>95</fpage>&#x2013;<lpage>114</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075035</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caton</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Kropf</surname> <given-names>E</given-names>
</name>
<name>
<surname>Simons</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Aitken</surname> <given-names>M</given-names>
</name>
<name>
<surname>Weissler</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Jordan</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>Strength of TCR Signal From Self-Peptide Modulates Autoreactive Thymocyte Deletion and Foxp3(+) Treg-Cell Formation</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>(<issue>3</issue>):<page-range>785&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201343767</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsieh</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Lio</surname> <given-names>CW</given-names>
</name>
</person-group>. <article-title>Selection of Regulatory T Cells in the Thymus</article-title>. <source>Nat Rev Immunol</source> (<year>2012</year>) <volume>12</volume>(<issue>3</issue>):<page-range>157&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3155</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Bautista</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Scott-Browne</surname> <given-names>J</given-names>
</name>
<name>
<surname>Mohan</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Hsieh</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>A Broad Range of Self-Reactivity Drives Thymic Regulatory T Cell Selection to Limit Responses to Self</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>37</volume>(<issue>3</issue>):<page-range>475&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2012.07.009</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konkel</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Abbatiello</surname> <given-names>B</given-names>
</name>
<name>
<surname>Grainger</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Thymocyte Apoptosis Drives the Intrathymic Generation of Regulatory T Cells</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2014</year>) <volume>111</volume>(<issue>4</issue>):<page-range>E465&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1320319111</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lio</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Hsieh</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>A Two-Step Process for Thymic Regulatory T Cell Development</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>28</volume>(<issue>1</issue>):<page-range>100&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2007.11.021</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burchill</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Vang</surname> <given-names>KB</given-names>
</name>
<name>
<surname>Moon</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>HH</given-names>
</name>
<name>
<surname>Lio</surname> <given-names>CW</given-names>
</name>
<etal/>
</person-group>. <article-title>Linked T Cell Receptor and Cytokine Signaling Govern the Development of the Regulatory T Cell Repertoire</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>28</volume>(<issue>1</issue>):<page-range>112&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2007.11.022</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tai</surname> <given-names>X</given-names>
</name>
<name>
<surname>Erman</surname> <given-names>B</given-names>
</name>
<name>
<surname>Alag</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kimura</surname> <given-names>M</given-names>
</name>
<name>
<surname>Katz</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Foxp3 Transcription Factor is Proapoptotic and Lethal to Developing Regulatory T Cells Unless Counterbalanced by Cytokine Survival Signals</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>(<issue>6</issue>):<page-range>1116&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2013.02.022</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tai</surname> <given-names>X</given-names>
</name>
<name>
<surname>Singer</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Basis of Treg Development in the Thymus</article-title>. <source>Cell Cycle</source> (<year>2014</year>) <volume>13</volume>(<issue>4</issue>):<page-range>501&#x2013;2</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/cc.27787</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owen</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Mahmud</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Sjaastad</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Spanier</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Simeonov</surname> <given-names>DR</given-names>
</name>
<etal/>
</person-group>. <article-title>Thymic Regulatory T Cells Arise <italic>via</italic> Two Distinct Developmental Programs</article-title>. <source>Nat Immunol</source> (<year>2019</year>) <volume>20</volume>(<issue>2</issue>):<fpage>195</fpage>&#x2013;<lpage>205</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-018-0289-6</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahmud</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Manlove</surname> <given-names>LS</given-names>
</name>
<name>
<surname>Schmitz</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Owen</surname> <given-names>DL</given-names>
</name>
<etal/>
</person-group>. <article-title>Costimulation <italic>via</italic> the Tumor-Necrosis Factor Receptor Superfamily Couples TCR Signal Strength to the Thymic Differentiation of Regulatory T Cells</article-title>. <source>Nat Immunol</source> (<year>2014</year>) <volume>15</volume>(<issue>5</issue>):<page-range>473&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.2849</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kulkarni</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Perruche</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>A Critical Function for TGF-Beta Signaling in the Development of Natural CD4+CD25+Foxp3+ Regulatory T Cells</article-title>. <source>Nat Immunol</source> (<year>2008</year>) <volume>9</volume>(<issue>6</issue>):<page-range>632&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1607</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schorle</surname> <given-names>H</given-names>
</name>
<name>
<surname>Holtschke</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hunig</surname> <given-names>T</given-names>
</name>
<name>
<surname>Schimpl</surname> <given-names>A</given-names>
</name>
<name>
<surname>Horak</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Development and Function of T Cells in Mice Rendered Interleukin-2 Deficient by Gene Targeting</article-title>. <source>Nature</source> (<year>1991</year>) <volume>352</volume>(<issue>6336</issue>):<page-range>621&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/352621a0</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadlack</surname> <given-names>B</given-names>
</name>
<name>
<surname>Merz</surname> <given-names>H</given-names>
</name>
<name>
<surname>Schorle</surname> <given-names>H</given-names>
</name>
<name>
<surname>Schimpl</surname> <given-names>A</given-names>
</name>
<name>
<surname>Feller</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Horak</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Ulcerative Colitis-Like Disease in Mice With a Disrupted Interleukin-2 Gene</article-title>. <source>Cell</source> (<year>1993</year>) <volume>75</volume>(<issue>2</issue>):<page-range>253&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0092-8674(93)80067-o</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schimpl</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hunig</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Immunopathology of Interleukin (IL) 2-Deficient Mice: Thymus Dependence and Suppression by Thymus-Dependent Cells With an Intact IL-2 Gene</article-title>. <source>J Exp Med</source> (<year>1995</year>) <volume>182</volume>(<issue>6</issue>):<page-range>1769&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.182.6.1769</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willerford</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ferry</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Davidson</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>A</given-names>
</name>
<name>
<surname>Alt</surname> <given-names>FW</given-names>
</name>
</person-group>. <article-title>Interleukin-2 Receptor Alpha Chain Regulates the Size and Content of the Peripheral Lymphoid Compartment</article-title>. <source>Immunity</source> (<year>1995</year>) <volume>3</volume>(<issue>4</issue>):<page-range>521&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/1074-7613(95)90180-9</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kundig</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Furlonger</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wakeham</surname> <given-names>A</given-names>
</name>
<name>
<surname>Timms</surname> <given-names>E</given-names>
</name>
<name>
<surname>Matsuyama</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor Beta</article-title>. <source>Science</source> (<year>1995</year>) <volume>268</volume>(<issue>5216</issue>):<page-range>1472&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.7770771</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farrar</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Fuller-Farrar</surname> <given-names>J</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>PL</given-names>
</name>
<name>
<surname>Hilfiker</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Stadler</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Farrar</surname> <given-names>WL</given-names>
</name>
</person-group>. <article-title>Thymoma Production of T Cell Growth Factor (Interleukin 2)</article-title>. <source>J Immunol</source> (<year>1980</year>) <volume>125</volume>(<issue>6</issue>):<page-range>2555&#x2013;8</page-range>.</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedmann</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Migone</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Russell</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>WJ</given-names>
</name>
</person-group>. <article-title>Different Interleukin 2 Receptor Beta-Chain Tyrosines Couple to at Least Two Signaling Pathways and Synergistically Mediate Interleukin 2-Induced Proliferation</article-title>. <source>Proc Natl Acad Sci U.S.A.</source> (<year>1996</year>) <volume>93</volume>(<issue>5</issue>):<page-range>2077&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.93.5.2077</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Ruscetti</surname> <given-names>FW</given-names>
</name>
<name>
<surname>Gallo</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Selective <italic>In Vitro</italic> Growth of T Lymphocytes From Normal Human Bone Marrows</article-title>. <source>Science</source> (<year>1976</year>) <volume>193</volume>(<issue>4257</issue>):<page-range>1007&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.181845</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godfrey</surname> <given-names>VL</given-names>
</name>
<name>
<surname>Wilkinson</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Russell</surname> <given-names>LB</given-names>
</name>
</person-group>. <article-title>X-Linked Lymphoreticular Disease in the Scurfy (Sf) Mutant Mouse</article-title>. <source>Am J Pathol</source> (<year>1991</year>) <volume>138</volume>(<issue>6</issue>):<page-range>1379&#x2013;87</page-range>.</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontenot</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Rasmussen</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Gavin</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Rudensky</surname> <given-names>AY</given-names>
</name>
</person-group>. <article-title>A Function for Interleukin 2 in Foxp3-Expressing Regulatory T Cells</article-title>. <source>Nat Immunol</source> (<year>2005</year>) <volume>6</volume>(<issue>11</issue>):<page-range>1142&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni1263</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D&#x2019;Cruz</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Development and Function of Agonist-Induced CD25+Foxp3+ Regulatory T Cells in the Absence of Interleukin 2 Signaling</article-title>. <source>Nat Immunol</source> (<year>2005</year>) <volume>6</volume>(<issue>11</issue>):<page-range>1152&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni1264</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furtado</surname> <given-names>GC</given-names>
</name>
<name>
<surname>Curotto de Lafaille</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Kutchukhidze</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lafaille</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Interleukin 2 Signaling Is Required for CD4(+) Regulatory T Cell Function</article-title>. <source>J Exp Med</source> (<year>2002</year>) <volume>196</volume>(<issue>6</issue>):<page-range>851&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20020190</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chorro</surname> <given-names>L</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chin</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Snapp</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Odagiu</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin 2 Modulates Thymic-Derived Regulatory T Cell Epigenetic Landscape</article-title>. <source>Nat Commun</source> (<year>2018</year>) <volume>9</volume>(<issue>1</issue>):<fpage>5368</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-018-07806-6</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soper</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Kasprowicz</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Ziegler</surname> <given-names>SF</given-names>
</name>
</person-group>. <article-title>Il-2rbeta Links Il-2r Signaling With Foxp3 Expression</article-title>. <source>Eur J Immunol</source> (<year>2007</year>) <volume>37</volume>(<issue>7</issue>):<page-range>1817&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.200737101</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leonard</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>JX</given-names>
</name>
<name>
<surname>O&#x2019;Shea</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>The Gammac Family of Cytokines: Basic Biology to Therapeutic Ramifications</article-title>. <source>Immunity</source> (<year>2019</year>) <volume>50</volume>(<issue>4</issue>):<page-range>832&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.028</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>JX</given-names>
</name>
<name>
<surname>Migone</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Tsang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Friedmann</surname> <given-names>M</given-names>
</name>
<name>
<surname>Weatherbee</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>The Role of Shared Receptor Motifs and Common Stat Proteins in the Generation of Cytokine Pleiotropy and Redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15</article-title>. <source>Immunity</source> (<year>1995</year>) <volume>2</volume>(<issue>4</issue>):<page-range>331&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/1074-7613(95)90141-8</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burchill</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Vogtenhuber</surname> <given-names>C</given-names>
</name>
<name>
<surname>Blazar</surname> <given-names>BR</given-names>
</name>
<name>
<surname>Farrar</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>IL-2 Receptor Beta-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>(<issue>1</issue>):<page-range>280&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.178.1.280</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vang</surname> <given-names>KB</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Mahmud</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Burchill</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Vegoe</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Farrar</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>IL-2, -7, and -15, But Not Thymic Stromal Lymphopoeitin, Redundantly Govern CD4+Foxp3+ Regulatory T Cell Development</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>(<issue>5</issue>):<page-range>3285&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.181.5.3285</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayer</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JY</given-names>
</name>
<name>
<surname>de la Barrera</surname> <given-names>A</given-names>
</name>
<name>
<surname>Surh</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Malek</surname> <given-names>TR</given-names>
</name>
</person-group>. <article-title>A Function for IL-7R for CD4+CD25+Foxp3+ T Regulatory Cells</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>(<issue>1</issue>):<page-range>225&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.181.1.225</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Kanno</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kerenyi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Stephens</surname> <given-names>G</given-names>
</name>
<name>
<surname>Durant</surname> <given-names>L</given-names>
</name>
<name>
<surname>Watford</surname> <given-names>WT</given-names>
</name>
<etal/>
</person-group>. <article-title>Nonredundant Roles for Stat5a/B in Directly Regulating Foxp3</article-title>. <source>Blood</source> (<year>2007</year>) <volume>109</volume>(<issue>10</issue>):<page-range>4368&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2006-11-055756</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burchill</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Goetz</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Prlic</surname> <given-names>M</given-names>
</name>
<name>
<surname>O&#x2019;Neil</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Harmon</surname> <given-names>IR</given-names>
</name>
<name>
<surname>Bensinger</surname> <given-names>SJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinct Effects of STAT5 Activation on CD4+ and CD8+ T Cell Homeostasis: Development of CD4+CD25+ Regulatory T Cells Versus CD8+ Memory T Cells</article-title>. <source>J Immunol</source> (<year>2003</year>) <volume>171</volume>(<issue>11</issue>):<page-range>5853&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.171.11.5853</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dikiy</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>L</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Janke</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zong</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>A Distal Foxp3 Enhancer Enables Interleukin-2 Dependent Thymic Treg Cell Lineage Commitment for Robust Immune Tolerance</article-title>. <source>Immunity</source> (<year>2021</year>) <volume>54</volume>(<issue>5</issue>):<fpage>931</fpage>&#x2013;<lpage>46.e11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2021.03.020</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawakami</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kitagawa</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>KY</given-names>
</name>
<name>
<surname>Arai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ohara</surname> <given-names>D</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinct Foxp3 Enhancer Elements Coordinate Development, Maintenance, and Function of Regulatory T Cells</article-title>. <source>Immunity</source> (<year>2021</year>) <volume>54</volume>(<issue>5</issue>):<fpage>947</fpage>&#x2013;<lpage>61.e8</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2021.04.005</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dardalhon</surname> <given-names>V</given-names>
</name>
<name>
<surname>Awasthi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>H</given-names>
</name>
<name>
<surname>Galileos</surname> <given-names>G</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sobel</surname> <given-names>RA</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-4 Inhibits TGF-Beta-Induced Foxp3+ T Cells and, Together With TGF-Beta, Generates IL-9+ IL-10+ Foxp3(-) Effector T Cells</article-title>. <source>Nat Immunol</source> (<year>2008</year>) <volume>9</volume>(<issue>12</issue>):<page-range>1347&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1677</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakatsukasa</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Maruyama</surname> <given-names>T</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ishikawa</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The DNA-Binding Inhibitor Id3 Regulates IL-9 Production in CD4(+) T Cells</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>(<issue>10</issue>):<page-range>1077&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.3252</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Interleukin-4 Inhibits Regulatory T Cell Differentiation Through Regulating Cd103+ Dendritic Cells</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<elocation-id>214</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.00214</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owen</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Sjaastad</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Farrar</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>Regulatory T Cell Development in the Thymus</article-title>. <source>J Immunol</source> (<year>2019</year>) <volume>203</volume>(<issue>8</issue>):<page-range>2031&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1900662</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Borde</surname> <given-names>M</given-names>
</name>
<name>
<surname>Heissmeyer</surname> <given-names>V</given-names>
</name>
<name>
<surname>Feuerer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lapan</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Stroud</surname> <given-names>JC</given-names>
</name>
<etal/>
</person-group>. <article-title>Foxp3 Controls Regulatory T Cell Function Through Cooperation With Nfat</article-title>. <source>Cell</source> (<year>2006</year>) <volume>126</volume>(<issue>2</issue>):<page-range>375&#x2013;87</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2006.05.042</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granucci</surname> <given-names>F</given-names>
</name>
<name>
<surname>Vizzardelli</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pavelka</surname> <given-names>N</given-names>
</name>
<name>
<surname>Feau</surname> <given-names>S</given-names>
</name>
<name>
<surname>Persico</surname> <given-names>M</given-names>
</name>
<name>
<surname>Virzi</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Inducible IL-2 Production by Dendritic Cells Revealed by Global Gene Expression Analysis</article-title>. <source>Nat Immunol</source> (<year>2001</year>) <volume>2</volume>(<issue>9</issue>):<page-range>882&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni0901-882</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owen</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Mahmud</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Vang</surname> <given-names>KB</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Blazar</surname> <given-names>BR</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>KA</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis</article-title>. <source>J Immunol</source> (<year>2018</year>) <volume>200</volume>(<issue>12</issue>):<page-range>3926&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1800097</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemmers</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schizas</surname> <given-names>M</given-names>
</name>
<name>
<surname>Azizi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Dikiy</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-2 Production by Self-Reactive CD4 Thymocytes Scales Regulatory T Cell Generation in the Thymus</article-title>. <source>J Exp Med</source> (<year>2019</year>) <volume>216</volume>(<issue>11</issue>):<page-range>2466&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20190993</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hara</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shitara</surname> <given-names>S</given-names>
</name>
<name>
<surname>Imai</surname> <given-names>K</given-names>
</name>
<name>
<surname>Miyachi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kitano</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of IL-7-Producing Cells in Primary and Secondary Lymphoid Organs Using IL-7-GFP Knock-in Mice</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>189</volume>(<issue>4</issue>):<page-range>1577&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1200586</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hara</surname> <given-names>T</given-names>
</name>
<name>
<surname>Simmons</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wagatsuma</surname> <given-names>K</given-names>
</name>
<name>
<surname>Abe</surname> <given-names>A</given-names>
</name>
<name>
<surname>Miyachi</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterization of the IL-15 Niche in Primary and Secondary Lymphoid Organs <italic>In Vivo</italic>
</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2014</year>) <volume>111</volume>(<issue>5</issue>):<page-range>1915&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1318281111</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kyewski</surname> <given-names>B</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Hogquist</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>Positive and Negative Selection of the T Cell Repertoire: What Thymocytes See (and Don&#x2019;t See)</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>(<issue>6</issue>):<page-range>377&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3667</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohkura</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kitagawa</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sakaguchi</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Development and Maintenance of Regulatory T Cells</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>(<issue>3</issue>):<page-range>414&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2013.03.002</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aschenbrenner</surname> <given-names>K</given-names>
</name>
<name>
<surname>D&#x2019;Cruz</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Vollmann</surname> <given-names>EH</given-names>
</name>
<name>
<surname>Hinterberger</surname> <given-names>M</given-names>
</name>
<name>
<surname>Emmerich</surname> <given-names>J</given-names>
</name>
<name>
<surname>Swee</surname> <given-names>LK</given-names>
</name>
<etal/>
</person-group>. <article-title>Selection of Foxp3+ Regulatory T Cells Specific for Self Antigen Expressed and Presented by Aire+ Medullary Thymic Epithelial Cells</article-title>. <source>Nat Immunol</source> (<year>2007</year>) <volume>8</volume>(<issue>4</issue>):<page-range>351&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni1444</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cowan</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Parnell</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>K</given-names>
</name>
<name>
<surname>Caamano</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Lane</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Jenkinson</surname> <given-names>EJ</given-names>
</name>
<etal/>
</person-group>. <article-title>The Thymic Medulla is Required for Foxp3+ Regulatory But Not Conventional CD4+ Thymocyte Development</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>(<issue>4</issue>):<page-range>675&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20122070</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Hardegen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Marinos</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Conversion of Peripheral CD4+CD25- Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-Beta Induction of Transcription Factor Foxp3</article-title>. <source>J Exp Med</source> (<year>2003</year>) <volume>198</volume>(<issue>12</issue>):<page-range>1875&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20030152</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
<name>
<surname>Ten Dijke</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Immunoregulation by Members of the Tgfbeta Superfamily</article-title>. <source>Nat Rev Immunol</source> (<year>2016</year>) <volume>16</volume>(<issue>12</issue>):<page-range>723&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri.2016.112</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marie</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Letterio</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Gavin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rudensky</surname> <given-names>AY</given-names>
</name>
</person-group>. <article-title>TGF-Beta1 Maintains Suppressor Function and Foxp3 Expression in CD4+CD25+ Regulatory T Cells</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>201</volume>(<issue>7</issue>):<page-range>1061&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20042276</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>MO</given-names>
</name>
<name>
<surname>Sanjabi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Flavell</surname> <given-names>RA</given-names>
</name>
</person-group>. <article-title>Transforming Growth Factor-Beta Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent Mechanisms</article-title>. <source>Immunity</source> (<year>2006</year>) <volume>25</volume>(<issue>3</issue>):<page-range>455&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2006.07.011</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marie</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Liggitt</surname> <given-names>D</given-names>
</name>
<name>
<surname>Rudensky</surname> <given-names>AY</given-names>
</name>
</person-group>. <article-title>Cellular Mechanisms of Fatal Early-Onset Autoimmunity in Mice With the T Cell-Specific Targeting of Transforming Growth Factor-Beta Receptor</article-title>. <source>Immunity</source> (<year>2006</year>) <volume>25</volume>(<issue>3</issue>):<page-range>441&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2006.07.012</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Josefowicz</surname> <given-names>SZ</given-names>
</name>
<name>
<surname>Niec</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Treuting</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chinen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Extrathymically Generated Regulatory T Cells Control Mucosal Th2 Inflammation</article-title>. <source>Nature</source> (<year>2012</year>) <volume>482</volume>(<issue>7385</issue>):<page-range>395&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature10772</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Josefowicz</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chaudhry</surname> <given-names>A</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>XP</given-names>
</name>
<name>
<surname>Forbush</surname> <given-names>K</given-names>
</name>
<name>
<surname>Rudensky</surname> <given-names>AY</given-names>
</name>
</person-group>. <article-title>Role of Conserved non-Coding DNA Elements in the Foxp3 Gene in Regulatory T-Cell Fate</article-title>. <source>Nature</source> (<year>2010</year>) <volume>463</volume>(<issue>7282</issue>):<page-range>808&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature08750</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konkel</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zanvit</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zangarle-Murray</surname> <given-names>T</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Transforming Growth Factor-Beta Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses</article-title>. <source>Immunity</source> (<year>2017</year>) <volume>46</volume>(<issue>4</issue>):<page-range>660&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2017.03.015</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ouyang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Beckett</surname> <given-names>O</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>MO</given-names>
</name>
</person-group>. <article-title>Transforming Growth Factor-Beta Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development</article-title>. <source>Immunity</source> (<year>2010</year>) <volume>32</volume>(<issue>5</issue>):<page-range>642&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2010.04.012</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sicurello</surname> <given-names>P</given-names>
</name>
<name>
<surname>Frank</surname> <given-names>M</given-names>
</name>
<name>
<surname>Orenstein</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Requirement for Transforming Growth Factor Beta1 in Controlling T Cell Apoptosis</article-title>. <source>J Exp Med</source> (<year>2001</year>) <volume>194</volume>(<issue>4</issue>):<page-range>439&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.194.4.439</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tone</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Furuuchi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kojima</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tykocinski</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Greene</surname> <given-names>MI</given-names>
</name>
<name>
<surname>Tone</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Smad3 and NFAT Cooperate to Induce Foxp3 Expression Through its Enhancer</article-title>. <source>Nat Immunol</source> (<year>2008</year>) <volume>9</volume>(<issue>2</issue>):<fpage>194</fpage>&#x2013;<lpage>202</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni1549</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Kameswaran</surname> <given-names>V</given-names>
</name>
<name>
<surname>Tone</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Liou</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Greene</surname> <given-names>MI</given-names>
</name>
<etal/>
</person-group>. <article-title>Development of Foxp3(+) Regulatory T Cells Is Driven by the C-Rel Enhanceosome</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>31</volume>(<issue>6</issue>):<page-range>932&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2009.10.006</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlenner</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Weigmann</surname> <given-names>B</given-names>
</name>
<name>
<surname>Ruan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>von Boehmer</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Smad3 Binding to the Foxp3 Enhancer is Dispensable for the Development of Regulatory T Cells With the Exception of the Gut</article-title>. <source>J Exp Med</source> (<year>2012</year>) <volume>209</volume>(<issue>9</issue>):<page-range>1529&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20112646</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surh</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Sprent</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>T-Cell Apoptosis Detected <italic>in Situ</italic> During Positive and Negative Selection in the Thymus</article-title>. <source>Nature</source> (<year>1994</year>) <volume>372</volume>(<issue>6501</issue>):<page-range>100&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/372100a0</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontenot</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Dooley</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Farr</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Rudensky</surname> <given-names>AY</given-names>
</name>
</person-group>. <article-title>Developmental Regulation of Foxp3 Expression During Ontogeny</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>202</volume>(<issue>7</issue>):<page-range>901&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20050784</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
<name>
<surname>Frank</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wahl</surname> <given-names>SM</given-names>
</name>
</person-group>. <article-title>TGF-Beta Released by Apoptotic T Cells Contributes to an Immunosuppressive Milieu</article-title>. <source>Immunity</source> (<year>2001</year>) <volume>14</volume>(<issue>6</issue>):<page-range>715&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1074-7613(01)00147-9</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perruche</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Saas</surname> <given-names>P</given-names>
</name>
<name>
<surname>Bluestone</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Cd3-Specific Antibody-Induced Immune Tolerance Involves Transforming Growth Factor-Beta From Phagocytes Digesting Apoptotic T Cells</article-title>. <source>Nat Med</source> (<year>2008</year>) <volume>14</volume>(<issue>5</issue>):<page-range>528&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm1749</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fadok</surname> <given-names>VA</given-names>
</name>
<name>
<surname>Bratton</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Konowal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Freed</surname> <given-names>PW</given-names>
</name>
<name>
<surname>Westcott</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Henson</surname> <given-names>PM</given-names>
</name>
</person-group>. <article-title>Macrophages That Have Ingested Apoptotic Cells <italic>In Vitro</italic> Inhibit Proinflammatory Cytokine Production Through Autocrine/Paracrine Mechanisms Involving TGF-Beta, PGE2, and PAF</article-title>. <source>J Clin Invest</source> (<year>1998</year>) <volume>101</volume>(<issue>4</issue>):<page-range>890&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI1112</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Travis</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Sheppard</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>TGF-Beta Activation and Function in Immunity</article-title>. <source>Annu Rev Immunol</source> (<year>2014</year>) <volume>32</volume>:<fpage>51</fpage>&#x2013;<lpage>82</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120257</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Mi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Walz</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Latent TGF-Beta Structure and Activation</article-title>. <source>Nature</source> (<year>2011</year>) <volume>474</volume>(<issue>7351</issue>):<page-range>343&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature10152</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barcellos-Hoff</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Dix</surname> <given-names>TA</given-names>
</name>
</person-group>. <article-title>Redox-Mediated Activation of Latent Transforming Growth Factor-Beta 1</article-title>. <source>Mol Endocrinol</source> (<year>1996</year>) <volume>10</volume>(<issue>9</issue>):<page-range>1077&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/mend.10.9.8885242</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Park</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>High Glucose Intake Exacerbates Autoimmunity Through Reactive-Oxygen-Species-Mediated Tgf-Beta Cytokine Activation</article-title>. <source>Immunity</source> (<year>2019</year>) <volume>51</volume>(<issue>4</issue>):<fpage>671</fpage>&#x2013;<lpage>81.e5</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2019.08.001</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Chia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jiao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Kasagi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>D-Mannose Induces Regulatory T Cells and Suppresses Immunopathology</article-title>. <source>Nat Med</source> (<year>2017</year>) <volume>23</volume>(<issue>9</issue>):<page-range>1036&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm.4375</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meylan</surname> <given-names>F</given-names>
</name>
<name>
<surname>Siegel</surname> <given-names>RM</given-names>
</name>
</person-group>. <article-title>TNF Superfamily Cytokines in the Promotion of Th9 Differentiation and Immunopathology</article-title>. <source>Semin Immunopathol</source> (<year>2017</year>) <volume>39</volume>(<issue>1</issue>):<page-range>21&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00281-016-0612-y</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Croft</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The Role of TNF Superfamily Members in T-Cell Function and Diseases</article-title>. <source>Nat Rev Immunol</source> (<year>2009</year>) <volume>9</volume>(<issue>4</issue>):<page-range>271&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri2526</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klinger</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Chmura</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Barczak</surname> <given-names>A</given-names>
</name>
<name>
<surname>Erle</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Killeen</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Thymic OX40 Expression Discriminates Cells Undergoing Strong Responses to Selection Ligands</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>(<issue>8</issue>):<page-range>4581&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0900010</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grinberg-Bleyer</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Saadoun</surname> <given-names>D</given-names>
</name>
<name>
<surname>Baeyens</surname> <given-names>A</given-names>
</name>
<name>
<surname>Billiard</surname> <given-names>F</given-names>
</name>
<name>
<surname>Goldstein</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Gregoire</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Pathogenic T Cells Have a Paradoxical Protective Effect in Murine Autoimmune Diabetes by Boosting Tregs</article-title>. <source>J Clin Invest</source> (<year>2010</year>) <volume>120</volume>(<issue>12</issue>):<page-range>4558&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI42945</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chopra</surname> <given-names>M</given-names>
</name>
<name>
<surname>Riedel</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Biehl</surname> <given-names>M</given-names>
</name>
<name>
<surname>Krieger</surname> <given-names>S</given-names>
</name>
<name>
<surname>von Krosigk</surname> <given-names>V</given-names>
</name>
<name>
<surname>Bauerlein</surname> <given-names>CA</given-names>
</name>
<etal/>
</person-group>. <article-title>Tumor Necrosis Factor Receptor 2-Dependent Homeostasis of Regulatory T Cells as a Player in TNF-Induced Experimental Metastasis</article-title>. <source>Carcinogenesis</source> (<year>2013</year>) <volume>34</volume>(<issue>6</issue>):<page-range>1296&#x2013;303</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/carcin/bgt038</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Baumel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mannel</surname> <given-names>DN</given-names>
</name>
<name>
<surname>Howard</surname> <given-names>OM</given-names>
</name>
<name>
<surname>Oppenheim</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Interaction of TNF With TNF Receptor Type 2 Promotes Expansion and Function of Mouse CD4+CD25+ T Regulatory Cells</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>(<issue>1</issue>):<page-range>154&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.179.1.154</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Howard</surname> <given-names>OM</given-names>
</name>
<name>
<surname>Netea</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Oppenheim</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T. Cell Phenotype in the Inflammatory Environment</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>(<issue>3</issue>):<page-range>1076&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1202659</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>